Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Aug;11(4):313-9.
doi: 10.1007/s11920-009-0045-6.

Neuropsychological abnormalities in schizophrenia and major mood disorders: similarities and differences

Affiliations
Review

Neuropsychological abnormalities in schizophrenia and major mood disorders: similarities and differences

Deanna M Barch. Curr Psychiatry Rep. 2009 Aug.

Abstract

The past 20 years have been witness to a growing knowledge base of research highlighting the critical importance of cognition in understanding functional status and outcome in schizophrenia. This work has led to an increased emphasis on identifying and evaluating treatments that enhance cognition in schizophrenia, with the hope that this would translate into a better quality of life and improved outcome for patients. At the same time, this research has raised new questions about the specificity of cognitive impairments to schizophrenia and the degree to which similar cognitive impairments may be present in other disorders that can involve psychotic symptoms (eg, schizoaffective disorder, bipolar disorder, and psychotic major depression). This article provides a brief overview of work comparing cognitive function across the nonaffective and affective psychoses and highlights areas of similarity and dissimilarity in the role cognition plays in these disorders.

PubMed Disclaimer

Conflict of interest statement

Disclosure

No potential conflict of interest relevant to this article was reported.

Figures

Figure 1
Figure 1
Neuropsychological performance profile of psychotic bipolar disorder, psychotic major depressive disorder, schizoaffective disorder, and schizophrenia patients (straight solid line indicates average normal performance). Raw data are available from the corresponding author.

Similar articles

Cited by

References

    1. Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”? Schizophr Bull. 2000;26:119–136. - PubMed
    1. Marder SR, Fenton W. Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. Schizophr Res. 2004;72:5–9. - PubMed
    1. Carter CS, Barch DM. Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative. Schizophr Bull. 2007;33:1131–1137. - PMC - PubMed
    1. Craddock N, O’Donovan MC, Owen MJ. Psychosis genetics: modeling the relationship between schizophrenia, bipolar disorder, and mixed (or “schizoaffective”) psychoses. Schizophr Bull. 2009;35:482–490. This article reviews recent research focused on identifying specific genetic contributions to risk for schizophrenia and other psychotic disorders. Importantly, it also reviews the evidence of common genetic influences on risk across the boundaries of psychotic disorders. The authors argue that such research challenges our traditional diagnostic categories and call for a reconceptualization of how to create a psychiatric nosology. - PMC - PubMed
    1. Depp CA, Moore DJ, Sitzer D, et al. Neurocognitive impairment in middle-aged and older adults with bipolar disorder: comparison to schizophrenia and normal comparison subjects. J Affect Disord. 2007;101:201–209. - PMC - PubMed

MeSH terms